Loading
Life sciences · Preprint
arXiv · October 6, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Preprint.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Web agents complete user requests by reading and acting on pages that third parties write, so an instruction planted on a page can redirect the agent away from the user's goal. The agent cannot simply ignore the page, because the page also holds the values and controls the task requires. Current defenses fine-tune the agent on injections fixed before training, and attackers that adapt to the trained model bypass them. Adversarial training lets the attacker adapt but keeps the tasks fixed, so a task stops teaching once the agent solves it. We introduce AdvSim2Real, which co-evolves a task curriculum, an injection adversary, and the agent inside a frozen web world model. The curriculum is rewarded for tasks the agent solves about half of the time, and the adversary only for a success flip, an injection that turns a judged success into a failure. Training in the simulator makes a 4B agent both more capable and more robust: its completion rises with and without attacks, holds against a frontier-model adversary it never trained against, and its capability gain carries over to a real browser. On 150 web tasks, AdvSim2Real raises completion under this unseen adversary by 33.6\% relative to the base agent.